HC Wainwright & Co. Maintains Buy on Armata Pharmaceuticals, Maintains $7 Price Target
HC Wainwright & Co. Maintains Buy on Armata Pharmaceuticals, Maintains $7 Price Target
HC Wainwright & Co.維持對Armata Pharmicals的買入,維持7美元的目標股價
HC Wainwright & Co. analyst Joseph Pantginis maintains Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 price target.
HC Wainwright & Co. 分析師約瑟夫·潘吉尼斯維持Armata Pharmicals(AMEX: ARMP)的買入並維持7美元的目標股價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。